
Veterans are at the center of the ibogaine movement. A landmark 2023 study showed ibogaine reduced PTSD symptoms by 88% in Special Operations veterans — and former Governor Rick Perry has made veteran access to ibogaine his personal mission.
A 2023 Nature Medicine study of 30 Special Operations veterans found ibogaine reduced PTSD symptom severity by an average of 88% at 1-month follow-up — results that stunned the research community.
Former Texas Governor Rick Perry has become one of the most prominent advocates for veteran access to ibogaine, testifying before the Texas Legislature and appearing twice on the Joe Rogan Experience.
The 2023 Nature Medicine study also found significant improvements in traumatic brain injury (TBI) symptoms — cognitive function, headaches, and neurological symptoms — alongside PTSD improvements.
Veterans require practitioners who understand military culture, combat trauma, and the specific challenges of veteran reintegration. Certified ibogaine coaches and facilitators with veteran-focused training are in high demand.
In January 2023, researchers at Stanford University published a landmark study in Nature Medicine examining ibogaine treatment in 30 US Special Operations Forces veterans. These were not typical PTSD patients — they were highly trained operators with complex trauma histories, many of whom had tried and failed multiple conventional treatments including SSRIs, therapy, and other interventions. The results were extraordinary.
PTSD symptom severity (measured by the PCL-5 scale) decreased by an average of 88% at 1-month follow-up. Disability scores (measured by the World Health Organization Disability Assessment Schedule) decreased by 78%. Cognitive function — including memory, attention, and executive function — improved significantly. Depression and anxiety scores dropped dramatically. And these improvements were maintained at 3-month follow-up in the majority of participants.
Former Texas Governor Rick Perry became an ibogaine advocate after witnessing its transformative effects on veterans he knew personally. Perry has spoken publicly about veterans who, after decades of PTSD and failed treatments, experienced profound healing following ibogaine treatment. His advocacy has been instrumental in securing Texas's $50M research investment and in building bipartisan political support for ibogaine research nationally.
Perry appeared on the Joe Rogan Experience twice — in January 2025 and April 2026 — to discuss ibogaine's potential for veterans and opioid patients. Both episodes generated millions of views and significantly increased public awareness of ibogaine as a legitimate medical treatment. The April 2026 appearance came just before President Trump signed an Executive Order directing the Department of Veterans Affairs to study ibogaine as a treatment for veteran PTSD.
Not currently through the VA or conventional healthcare — ibogaine is Schedule I federally. However, several nonprofit organizations help veterans access ibogaine treatment at clinics in Mexico and Costa Rica. The VA is now studying ibogaine following Trump's Executive Order.
Former Governor Perry has been one of the most prominent political advocates for ibogaine research and veteran access. He testified before the Texas Legislature in support of the $50M research appropriation and has used his public platform to raise awareness of ibogaine's potential.
Yes. Several organizations — including Heroic Hearts Project and VETS (Veterans Exploring Treatment Solutions) — help veterans access ibogaine treatment and integration support. These organizations often look for certified practitioners to support their programs.
Working with veterans requires understanding military culture, combat trauma, moral injury, and the specific challenges of veteran reintegration. Our Tier 1 curriculum includes trauma-informed integration frameworks, and we recommend additional training in veteran-specific mental health approaches.
Texas is leading the nation in ibogaine research. Be among the first certified practitioners in your region before demand outpaces supply.